Literature DB >> 2117525

Regulation and cellular localization of the membrane-bound thyrotropin-releasing hormone-degrading enzyme in primary cultures of neuronal, glial and adenohypophyseal cells.

K Bauer1, P Carmeliet, M Schulz, M Baes, C Denef.   

Abstract

Using monolayer cultures from murine brain and reaggregate cell cultures of rat anterior pituitary we observed that TRH (pyroGlu-His-Pro-NH2) added to the culture medium was not taken up by these cells but hydrolyzed at the pyroGlu-His bond by an enzyme obviously located at the cell surface. This enzyme exhibited a high degree of substrate specificity and other characteristics of the membrane-bound TRH-degrading enzyme. Relatively high enzymatic activity was associated with cultured neuronal cells from embryonic rat brain while glial cells were almost devoid of this peptidase activity. Rather low, but significant activity was found on anterior pituitary cell aggregates. In agreement with previous in vivo studies we observed that the TRH-degrading ectoenzyme on adenohypophyseal cells was regulated by estradiol and stringently controlled by T3, but that the activity of the brain enzyme was not. When pituitary cells were separated according to their size and density and established in reaggregate cell culture, a close correlation was always observed between enzyme activity and the distribution of lactotrophic cells regardless of the animal models (eu- and hypothyroid adult male rats) used and the cell fractionation techniques (velocity sedimentation and sequential velocity/buoyant density sedimentation) employed. Such a close correlation was not observed with other cell types, such as the somatotrophic cells, the folliculo-stellate cells, the ACTH-producing AtT20 pituitary cells, or thyrotrophic cells. In conclusion, the high degree of substrate specificity, the tissue-specific regulation, and the very heterogeneous distribution of the TRH-degrading ectoenzyme on brain and pituitary cells strongly support the hypothesis that this enzyme serves very specialized functions in the transmission of TRH signals at specific target sites.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117525     DOI: 10.1210/endo-127-3-1224

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  The ups and downs of thyrotropin-releasing hormone.

Authors:  Kristen R Vella; Anthony N Hollenberg
Journal:  Endocrinology       Date:  2009-05       Impact factor: 4.736

2.  Peptide modification by incorporation ofα-trifluoromethyl substituted amino acids.

Authors:  B Koksch; N Sewald; K Burger; H D Jakubke
Journal:  Amino Acids       Date:  1996-09       Impact factor: 3.520

3.  Regulation of adenohypophyseal pyroglutamyl aminopeptidase II activity by thyrotropin-releasing hormone and phorbol esters.

Authors:  M A Vargas; M Cisneros; P Joseph-Bravo; J L Charli
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 4.  Multifactorial modulation of TRH metabolism.

Authors:  P Joseph-Bravo; R M Uribe; M A Vargas; L Pérez-Martínez; T Zoeller; J L Charli
Journal:  Cell Mol Neurobiol       Date:  1998-04       Impact factor: 5.046

5.  Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence.

Authors:  Edith Sánchez; Miguel Angel Vargas; Praful S Singru; Isel Pascual; Fidelia Romero; Csaba Fekete; Jean-Louis Charli; Ronald M Lechan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

6.  Identification of the thyrotropin-releasing-hormone-degrading ectoenzyme as a metallopeptidase.

Authors:  G Czekay; K Bauer
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

7.  Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin-releasing hormone.

Authors:  B Schauder; L Schomburg; J Köhrle; K Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

Review 8.  Advances in TRH signaling.

Authors:  Patricia Joseph-Bravo; Lorraine Jaimes-Hoy; Jean-Louis Charli
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

Review 9.  The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

Authors:  Jean-Louis Charli; Adair Rodríguez-Rodríguez; Karina Hernández-Ortega; Antonieta Cote-Vélez; Rosa María Uribe; Lorraine Jaimes-Hoy; Patricia Joseph-Bravo
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

Review 10.  Cell-surface peptidases.

Authors:  Rolf Mentlein
Journal:  Int Rev Cytol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.